Concepedia

Tamer Elbayoumi

TE

Statistics

Publications

21

Citations

1.6K

H-Index

19

Active since

2004

Affiliations

Midwestern University(Current)

Northeastern University

Vifor Pharma (Switzerland)

Tamer Elbayoumi is an author at Midwestern University specializing in medicine, nanomedicine, and pharmacology.

ORCID

Top concepts

Publications per year

2004–2022

21

Publications

21

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

Anatoly N. Lukyanov, Tamer Elbayoumi, Ananthsrinivas Chakilam et al. · Journal of Controlled Release · 2004 · 293 citations

, , +3

Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy <i>In vivo</i> of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody

Tamer Elbayoumi, Vladimir P. Torchilin · Clinical Cancer Research · 2009 · 168 citations · Full text

Mixed micelles made of poly(ethylene glycol)–phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin

Tamer Elbayoumi, Vladimir P. Torchilin · International Journal of Pharmaceutics · 2005 · 160 citations · Full text

, , +14

Current Trends in Liposome Research

Tamer Elbayoumi, Vladimir P. Torchilin · Methods in molecular biology · 2009 · 132 citations

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

Tamer Elbayoumi, Vladimir P. Torchilin · European Journal of Pharmaceutical Sciences · 2007 · 106 citations · Full text

, , +8

1–5 of 21